Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P36
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.06% |
| Q3 2025 | 3.57% |
| Q2 2025 | 4.17% |
| Q1 2025 | -8.65% |
| Q4 2024 | 13.61% |
| Q3 2024 | -3.03% |
| Q2 2024 | 11.75% |
| Q1 2024 | -10.37% |
| Q4 2023 | 7.55% |
| Q3 2023 | 2.40% |
| Q2 2023 | 8.93% |
| Q1 2023 | 1.17% |
| Q4 2022 | -5.78% |
| Q3 2022 | -1.68% |
| Q2 2022 | -2.57% |
| Q1 2022 | 1.44% |
| Q4 2021 | 29.13% |
| Q3 2021 | -7.25% |
| Q2 2021 | 14.44% |
| Q1 2021 | -8.36% |
| Q4 2020 | 9.36% |
| Q3 2020 | 64.46% |
| Q2 2020 | -29.96% |
| Q1 2020 | -16.09% |
| Q4 2019 | 9.88% |
| Q3 2019 | 6.43% |
| Q2 2019 | 20.92% |
| Q1 2019 | -10.02% |
| Q4 2018 | 10.49% |
| Q3 2018 | 1.89% |
| Q2 2018 | 22.17% |
| Q1 2018 | -10.49% |
| Q4 2017 | 17.67% |
| Q3 2017 | 4.21% |
| Q2 2017 | 5.42% |
| Q1 2017 | -9.29% |
| Q4 2016 | 95.54% |
| Q3 2016 | -45.90% |
| Q2 2016 | 3.08% |
| Q1 2016 | -9.41% |